Psoriasis versus psoriasiform drug eruption

Psoriasiform Drug Eruption Associated with Sodium Valproate

As psoriasis is a common skin disorder, knowledge of the factors that may induce, trigger, or exacerbate the disease is of primary importance in clinical practice. Drug intake is a major concern in this respect, as new drugs are constantly being added to the list of factors that may influence the course of the disease. We report a patient with a psoriasiform drug eruption associated with the us...

Psoriasiform drug eruption due to abatacept.

A 59-year-old woman presented with a 4-month history of erythematous plaques on her palms and extremities. The patient had a long-term history of using methotrexate (8 mg/week) and oral prednisolone (10 mg/day) as therapy for RA, which had been diagnosed at the age of 37. Laboratory findings were as follows: white blood cell count 10,300 /μl; C-reactive protein 1.27 mg/dl (normal < 0.3 mg/dl); ...

Psoriasiform eruption associated with graft-versus-host disease.

Graft-versus-host disease (GVHD) is a frequent complication of bone marrow transplantation (BMT) that can be classified as acute or chronic. Characteristic cutaneous manifestations of acute GVHD, which generally occurs within 3 months following BMT, include maculopapular exanthema and perifollicular papular lesions. Psoriasiform skin eruption as a manifestation of acute GVHD is rare. We report ...

Psoriasiform skin eruption associated with sorafenib therapy.

A rare side effect seen due to the use of apixaban: Palmoplantar psoriasiform drug eruption

Psoriasiform drug eruptions are very rare and generally characterized as erythematous, thick, dry, squamous, and demarcated plaques, resembling those of idiopathic psoriasis (1). Drugs may result in the exacerbation of pre-existing psoriasis or initiation of de novo psoriatic lesions (2). Apixaban, a reversible direct inhibitor factor Xa, is a novel anticoagulant, and its side effects mainly in...